Decarbonizing industry, favoring health autonomy for France, and inventing novel biotech processes are all examples of crucial advances addressable through partnerships. Corporations and investors in biotech are very interested in the innovations forwarded by Genopole’s start-ups. Hence the interest of Partnering Week, held 16–20 October, at which 50 start-ups presented their advanced technologies. Among them were Algentech, Nutropy, DNTech, STH Biotech, bYoRNA, Kyron.bio and CGenetix, who stand out for the competitiveness of their innovations. The five-day online event favored partnerships (financing, R&D, licensing, commercialization), biotech innovation, the exploration of new markets and the establishment of durable relationships to advance together.
Enterome’s participation at the 2023 Genopole Partnering Week not only rekindled discussions with previously identified potential partners but also enabled the establishment of new, promising contacts with companies encountered in earlier events and with whom discussions are currently underway. The more intimate nature of the Partnering Week format eases the organization of meetings with actors in the pharmaceutical industry.
Laurent Chene,
Head of the Drug Discovery Platform
